A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Name: A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Published: 2023
License: Public Domain

Fore Biotherapeutics · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

low-grade-glioma

cancer harboring braf alterations, hgg, lgg, solid tumors, braf alterations, braf fusions, braf v600e, braf class 1, braf class 2, high grade glioma, low grade glioma, biliary tract cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 813950
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.